학술논문

Extravazation of therapeutic yttrium-90-ibritumomab tiuxetan (zevalin): a case report.
Document Type
Journal Article
Source
Cancer Biotherapy & Radiopharmaceuticals. Apr2006, Vol. 21 Issue 2, p101-105. 5p.
Subject
*MONOCLONAL antibodies
*RADIATION injuries
*RADIOIMMUNOTHERAPY
*RADIOISOTOPES
*EXTRAVASATION
Language
ISSN
1084-9785
Abstract
The occurrence of radiation necrosis to the extravasation of therapeutic radionuclide-yttrium-90-ibritumomab tiuxetan-is described, as well as the subsequent steps taken to both address the occurrence and to prevent the re-occurrence of such an adverse event. Published reports on the extravasation of diagnostic and therapeutic radionuclides are reviewed, as are prevention and treatment protocols. [ABSTRACT FROM AUTHOR]